STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
Clinical trial NCT00526396 · UNKNOWN
Trial details
- NCT number
- NCT00526396
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2023-12-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.